DXCM vs NCL · P/E 63, rev $2.50B vs rev $5.0M
DexCom Inc (DXCM) versus Northann Corp. (NCL) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Northann Corp. (NCL) is a furnishings, fixtures & appliances company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported NCL revenue for 2026-03-31 was $5.0M. Net income was -$2.9M. Revenue was up 39.9% from 2025-09-30 to 2026-03-31. NCL currently screens at market cap $9.1M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. NCL currently screens at market cap $9.1M.
Not investment advice. Open the DXCM and NCL stock pages for the full models.
Not investment advice.